LIBMELDY 2-10 x 1 000 000 cells / ml, dispersion for infusion bag
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Dispersion for infusionbagintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LIBMELDY 2-10 x 1 000 000 cellules / ml, dispersion pour perfusion
- Pharmaceutical form
- dispersion pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- poche (s) EVA : éthylène vinyl acétate copolymère suremballée(s)/surpochée(s) de 10 - 20 mL - 1 ou plusieurs poches
- Marketing authorisation holder
- ORCHARD THERAPEUTICS (NETHERLANDS) (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Nov 2021
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
63621440CIP75507952CIP133400955079521Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| POPULATION ENRICHIE EN CELLULES CD34+ AUTOLOGUES CONTENANT DES CELLULES SOUCHES ET PROGÉNITRICES HÉMATOPOÏÉTIQUES TRANSDUITES EX VIVO AVEC UN VECTEUR LENTIVIRAL CODANT POUR L’ARYLSULFATASE A (ARSA) HUMAINEdispersion | 2-10 x 1 000 000 cellules · 1 mL de dispersion | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.